Life Sciences Ai

Clinical data harmonization is the bottleneck for life sciences AI

Commentary argues life sciences AI hinges on clean, harmonized trial data that’s ready for machine learning pipelines—not just better models.

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics names Neil Anderson, Ph.D. as CRO to commercialize its nanoimprint flat optics platform across AI datacenters, AR, and life sciences.

Biopharma's $300 Billion Patent Cliff Is Driving Its Strongest M&A Cycle Since the Pre-Pandemic Peak

More than $300 billion in branded pharmaceutical revenue faces patent expiration by 2030. Big Pharma cannot replace it through internal R&D alone. The result is the most aggressive acquisition cycle since before the pandemic, and it is reshaping how the entire life sciences supply chain does business.

AI-Driven Amino Acid Drugs Surface as a Promising Treatment for Eye Conditions

The rapid evolution of artificial intelligence (AI) promises to revolutionize multiple sectors, and one area seeing tangible benefits is drug development. Historically, the creation of new medicines was a time-consuming endeavor, but AI-driven amino acid research is proving to accelerate the early developmental stages and get drugs to the market faster. Researchers at the Wilmer…